Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DSM Solutech was a Dutch technology company and a subsidiary of Royal DSM, specializing in the development and manufacture of high-performance microporous membranes. Its flagship technology, Solupor, is a specialty membrane made from ultra-high molecular weight polyethylene (UHMWPE) known for its high porosity, mechanical strength, and chemical inertness. These membranes are utilized across diverse sectors, including air and liquid filtration, energy storage (batteries and fuel cells), and life sciences, specifically for transdermal drug delivery systems. In December 2008, the company was acquired by Lydall, Inc. and integrated into its Performance Materials division to expand its filtration and life sciences portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSM Solutech.